Designed for localized mucosal absorption, this delivery system utilizes a fatty acid base that melts at body temperature to release the active pharmaceutical ingredients.
- The Ellage® Anhydrous component is engineered to be mucoadhesive, maintaining contact with the mucosal lining for a sustained period.
- This formulation allows for the precise combination of Estradiol (E2), Estriol (E3), and Progesterone in ratios specifically requested by the prescribing clinician to meet the patient's unique physiological requirements.